Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
about
The role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationThe role of concomitant extracorporeal photopheresis for the treatment of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationExtracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantationExtracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current DogmaThe role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host diseaseExtracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.Guidelines on the use of extracorporeal photopheresisModified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse modelExtracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy.Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantationExtracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.Rippled skin, fasciitis, and joint contractures.Extracorporeal photopheresis in graft-versus-host disease.U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells.Immunoregulation of GVHD by triggering the innate immune system with CpG.Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.Current clinical applications of extracorporeal photochemotherapy.Extracorporeal photopheresis in pediatric patients: Practical and technical considerations.Comparison of two automated mononuclear cell collection systems in patients undergoing extracorporeal photopheresis: a prospective crossover equivalence study.Extracorporeal photopheresis: Review of technical aspectsPhotochemotherapy induces the apoptosis of monocytes without impairing their function.In vitro effects of different 8-methoxypsoralen treatment protocols for extracorporeal photopheresis on mononuclear cellsUse of cryopreserved autologous cells for extracorporeal photochemotherapy: clinical applications.Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.Modulation of lymphocyte subpopulations by extracorporeal photopheresis in patients with acute graft-versus-host disease or graft rejection.Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients.
P2860
Q24186279-730739D0-D40D-451C-8443-33F8B55EA57AQ24198004-6713FFE5-5696-4D6B-B038-9DAE7BC55897Q26740624-8A8AA93A-B545-4E1F-8D5B-39C0071E793EQ26798468-DE49569E-BF2B-42E6-B416-5683E56BF468Q33625948-72B104CE-E272-4B02-B709-340B6C9B0419Q34667586-3EA2CB6A-A213-454F-B5CB-ECE6E9DCA59FQ34870346-2BADD390-514D-4D3B-8C01-38EA5D1F09E1Q34918643-FC21FF79-1FF9-49E7-8DB4-C8D31438BFA6Q35229872-0FB8A363-066E-438A-92BA-7F419C06B4DAQ35495340-47B76573-42BE-430A-9AA3-48039763DEA0Q35737437-56B3FFF5-BB01-4C59-BF61-AE7CBE481372Q35876581-B4E79834-4984-457F-9ABC-4CED6BC5A6B8Q36444629-70BA2DF6-B853-4A77-AA41-341C3316D673Q36835217-D730C6C8-50F7-4D39-948D-C0CA395AA000Q36925994-DC923E1B-13BC-44ED-93C0-1B29DE31539DQ36991852-A31C9DC7-B6A0-4C77-959B-2B3EE98F3CA6Q37051405-71744BDA-6BF8-4AD3-A871-03896121BCE1Q37074253-F6F6A733-57FF-42A5-9FF0-326C5E40C043Q37483362-60D084CA-647A-4067-83E5-56D45D0B7F49Q37810081-5D8EB2E0-13E1-41AC-91FA-9DFE53C47450Q38226527-30FAB114-F9AA-4CAF-87AF-1E61D4DE9894Q38264394-8248650A-6C32-4760-8390-45FF4981A37AQ39183539-F4EBF640-340D-45EA-B9BC-46434415D2FAQ40724500-FCECF9C7-DC68-4E9A-BC5A-2827BE8CE33CQ41953441-93508E52-C599-4EB7-B948-46BC7B435A64Q42161868-B02D0084-1250-445C-A56E-F9F3700E0E7CQ42203241-E2FAEF91-D878-4938-A112-06F3806A582DQ44326460-FF053800-0F07-40CC-A5A9-28ECB89DBF9BQ46460065-46D61930-FFA2-4440-A984-0A55F705510FQ47579295-A16ACAFA-A15B-4F90-A676-F68E7C691CBEQ50495080-AAD1D0DB-8BA9-4572-8F80-AA7EC455A26AQ50800196-DE2B1A2C-05BB-422C-BFAD-6D8AD968E27EQ54390879-89ED0048-BB2E-489A-A7A7-B4DC17181DD2
P2860
Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Technology insight: ECP for th ...... generalized immunosuppression?
@ast
Technology insight: ECP for th ...... generalized immunosuppression?
@en
type
label
Technology insight: ECP for th ...... generalized immunosuppression?
@ast
Technology insight: ECP for th ...... generalized immunosuppression?
@en
prefLabel
Technology insight: ECP for th ...... generalized immunosuppression?
@ast
Technology insight: ECP for th ...... generalized immunosuppression?
@en
P2860
P356
P1476
Technology insight: ECP for th ...... generalized immunosuppression?
@en
P2093
Scott R Marshall
P2860
P304
P356
10.1038/NCPONC0511
P577
2006-06-01T00:00:00Z